We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$791M
AUM Growth
+$381M
Cap. Flow
+$153M
Cap. Flow %
19.34%
Top 10 Hldgs %
58.6%
Holding
63
New
9
Increased
16
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
PCG icon
PG&E
PCG
+$18.4M
2
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$17.5M
3
CI icon
Cigna
CI
+$15.7M
4
PGR icon
Progressive
PGR
+$14.9M
5
TIF
Tiffany & Co.
TIF
+$12.1M

Top Sells

Rank Stock Value
1
PFSI icon
PennyMac Financial
PFSI
+$11.5M
2
GPRE icon
Green Plains
GPRE
+$5.8M
3
KFY icon
Korn Ferry
KFY
+$5.54M
4
ECHO
EchoStar
ECHO
+$2.83M
5
AAMI
Acadian Asset Management
AAMI
+$2.29M

Sector Composition

Rank Sector Weight
1 Healthcare 14.63%
2 Financials 9.21%
3 Industrials 8.56%
4 Materials 7.18%
5 Energy 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCG icon
1
PG&E
PCG
$47.8B
$43.2M 5.47%
4,604,967
+1,987,223
+76% +$18.4M
CIVI
2
DELISTED
Civitas Resources
CIVI
$38.7M 4.9%
2,060,700
– –
GPRE icon
3
Green Plains
GPRE
$1.19B
$32.8M 4.14%
2,117,489
-423,561
-17% -$5.8M
AAMI
4
Acadian Asset Management
AAMI
$2.88B
$26.9M 3.4%
2,083,322
-173,851
-8% -$2.29M
SMCI icon
5
Super Micro Computer
SMCI
$19.5B
$25.8M 3.26%
9,776,450
+450,000
+5% +$1.23M
ECHO
6
EchoStar
ECHO
$25.5B
$24.4M 3.08%
980,201
-101,548
-9% -$2.83M
CAI
7
DELISTED
CAI International, Inc.
CAI
$23.3M 2.94%
845,512
– –
BMY.RT
8
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$22.7M 2.87%
10,085,813
+6,139,668
+156% +$17.5M
CCXI
9
DELISTED
ChemoCentryx, Inc.
CCXI
$19.4M 2.45%
353,219
+209,104
+145% +$11.3M
TGTX icon
10
TG Therapeutics
TGTX
$8.58B
$18.4M 2.33%
688,224
– –
PGR icon
11
Progressive
PGR
$124B
$17.6M 2.23%
186,197
+165,803
+813% +$14.9M
SXC icon
12
SunCoke Energy
SXC
$757M
$17.3M 2.19%
5,064,763
-58,312
-1% -$190K
BLUE
13
DELISTED
bluebird bio
BLUE
$15.3M 1.93%
21,854
+11,847
+118% +$9.24M
CI icon
14
Cigna
CI
$76.6B
$15.1M 1.91%
+89,108
New +$15.7M
AMP icon
15
Ameriprise Financial
AMP
$46.8B
$14.9M 1.88%
96,615
+53,314
+123% +$8.21M
KBR icon
16
KBR
KBR
$4.68B
$14.6M 1.84%
652,615
+250,116
+62% +$5.8M
MESO
17
PUT
Mesoblast
MESO
$1.99B
$12.6M 1.59%
+337,650
New +$10.6M
IOVA icon
18
Iovance Biotherapeutics
IOVA
$2.23B
$12.5M 1.58%
379,188
+315,465
+495% +$9.67M
COLL icon
19
Collegium Pharmaceutical
COLL
$1.14B
$12.4M 1.56%
+593,741
New +$10.7M
PWR icon
20
Quanta Services
PWR
$93.9B
$12.3M 1.56%
232,725
+68,807
+42% +$3.2M
TIF
21
DELISTED
Tiffany & Co.
TIF
$11.6M 1.46%
+100,000
New +$12.1M
RNAC icon
22
Cartesian Therapeutics
RNAC
$232M
$9.49M 1.2%
192,886
-25,340
-12% -$1.94M
CPRX
23
DELISTED
Catalyst Pharmaceutical
CPRX
$9.01M 1.14%
3,031,965
-98,230
-3% -$384K
GNK icon
24
Genco Shipping & Trading
GNK
$1.17B
$8.98M 1.14%
1,302,158
-64,926
-5% -$438K
EIGR
25
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$8.89M 1.12%
36,413
+4,818
+15% +$1.5M
1
2 3

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Mangrove Partners held 63 positions worth $791M, up 93% from $410M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Mangrove Partners deployed $153M of net new capital in Q3 2020, opening 9 new positions and adding to 16 existing holdings. Its largest new stake was Cigna: 89,108 shares worth $15.1M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Green Plains, an estimated $5.8M trimmed.

  • Mangrove Partners's largest Q3 2020 buy was Cigna: 89,108 shares worth $15.1M.
  • Mangrove Partners added most to PG&E in Q3 2020, an estimated $18.4M increase.
  • Mangrove Partners's biggest Q3 2020 reduction was Green Plains, cutting an estimated $5.8M.
  • Mangrove Partners fully exited PennyMac Financial in Q3 2020, selling an estimated $11.5M.
  • Mangrove Partners's ten largest holdings make up 59% of its $791M portfolio in Q3 2020.
  • Mangrove Partners opened 9 new positions and closed 11 in Q3 2020.
  • Mangrove Partners's portfolio value rose 93% quarter-over-quarter to $791M.

Based on Mangrove Partners's 13F filing for Q3 2020, filed 16 Nov 2020.